| dc.contributor.author | PARCU, Pier Luigi | |
| dc.contributor.author | ROSSI, Maria Alessandra | |
| dc.date.accessioned | 2016-03-15T13:46:06Z | |
| dc.date.available | 2016-03-15T13:46:06Z | |
| dc.date.issued | 2011 | |
| dc.identifier.citation | European journal of risk regulation, 2011, Vol. 2, No. 2, pp. 260-262 | |
| dc.identifier.issn | 1867-299X | |
| dc.identifier.uri | https://hdl.handle.net/1814/40194 | |
| dc.description.abstract | On 17 January 2011, the European Commission launched , a monitoring exercise of patent settlements in the pharmaceutical sector for the second time after the Pharmaceutical sector inquiry of 2009. | |
| dc.language.iso | en | |
| dc.relation.ispartof | European journal of risk regulation | |
| dc.relation.uri | http://ejrr.lexxion.eu/article/EJRR/2011/2/111 | |
| dc.title | Reverse payment settlements in the pharmaceutical sector : a European perspective | |
| dc.type | Article | |
| dc.identifier.volume | 2 | |
| dc.identifier.startpage | 260 | |
| dc.identifier.endpage | 262 | |
| dc.identifier.issue | 2 | |